文献速递临床试验与 GCP真实世界研究与卫生经济

以患者为中心过渡期护理对心衰住院患者临床结局的影响:PACT-HF随机临床试验

Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure: The PACT-HF Randomized Clinical Trial.
PubMed 文献 · JAMA · 2019-01-01

该阶梯楔形整群随机试验在加拿大安大略省10家医院纳入2494例心衰住院成人,评估以患者为中心的过渡期护理模型与常规护理的差异。结果显示,干预组与常规护理组在3个月复合再入院、急诊就诊或死亡以及30天复合再入院或急诊就诊方面均无显著差异,但干预组在出院准备度、过渡质量和生活质量等次要结局上有显著改善。

要点

  • 以患者为中心的过渡期护理未改善心衰患者3个月和30天复合临床结局。
  • 干预组在6周出院准备度和过渡质量评分上显著优于常规护理组。
  • 干预组在6周和6个月生活质量评分上有显著改善,但QALY无差异。

核心结论

  • 在加拿大安大略省心衰住院患者中,实施以患者为中心的过渡期护理模型与常规护理相比,未改善复合临床结局。
  • 该类型干预是否在其他医疗系统或地区有效尚需进一步研究。

研究设计与样本

  • 阶梯楔形整群随机试验,纳入加拿大安大略省10家医院2494例心衰住院成人,2015年2月至2016年3月入组,随访至2016年11月。
  • 干预组1104例接受护士主导的自我护理教育、结构化出院摘要、出院后1周内家庭医生随访,高危患者另接受结构化护士家访和心功能门诊护理;常规护理组1390例由临床医生酌情决定过渡期护理。

主要发现

  • 第一主要复合结局(3个月全因再入院、急诊就诊或死亡):干预组545例(49.4%) vs 常规护理组698例(50.2%),HR 0.99(95% CI 0.83-1.19),无显著差异。
  • 第二主要复合结局(30天全因再入院或急诊就诊):干预组304例(27.5%) vs 常规护理组408例(29.3%),HR 0.93(95% CI 0.73-1.18),无显著差异。
  • 6周B-PREPARED评分(范围0最佳至22最差):干预组均值16.6 vs 常规护理组13.9,差异2.65(95% CI 1.37-3.92),P < .001。
  • 6周CTM-3评分(范围0最差至100最佳):干预组均值76.5 vs 常规护理组70.3,差异6.16(95% CI 0.90-11.43),P = .02。
  • 6周EQ-5D-5L评分(范围0死亡至1完全健康):干预组均值0.7 vs 常规护理组0.7,差异0.06(95% CI 0.01-0.11),P = .02;6个月干预组0.7 vs 常规护理组0.6,差异0.06(95% CI 0.01-0.12),P = .02;6个月QALY(范围0死亡至0.5完全健康)均值0.3 vs 0.3,差异0.00(95% CI -0.02至0.02),P = .98。

临床怎么用

  • 该过渡期护理模型虽未改善再入院、急诊就诊或死亡等硬终点,但可改善患者出院准备度、过渡体验和生活质量。
  • 临床实施时应关注患者报告结局,而非仅以降低再入院率为目标。

局限性

  • 研究仅纳入加拿大安大略省10家医院的心衰患者,结果外推至其他医疗系统或地区需谨慎。
  • 干预效果可能受当地常规护理水平影响,未在其他地区验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Health care services that support the hospital-to-home transition can improve outcomes in patients with heart failure (HF). OBJECTIVE: To test the effectiveness of the Patient-Centered Care Transitions in HF transitional care model in patients hospitalized for HF. DESIGN, SETTING, AND PARTICIPANTS: Stepped-wedge cluster randomized trial of 2494 adults hospitalized for HF across 10 hospitals in Ontario, Canada, from February 2015 to March 2016, with follow-up until November 2016. INTERVENTIONS: Hospitals were randomized to receive the intervention (n = 1104 patients), in which nurse-led self-care education, a structured hospital discharge summary, a family physician follow-up appointment less than 1 week after discharge, and, for high-risk patients, structured nurse homevisits and heart function clinic care were provided to patients, or usual care (n = 1390 patients), in which transitional care was left to the discretion of clinicians. MAIN OUTCOMES AND MEASURES: Primary outcomes were hierarchically ordered as composite all-cause readmission, emergency department (ED) visit, or death at 3 months; and composite all-cause readmission or ED visit at 30 days. Secondary outcomes were B-PREPARED score for discharge preparedness (range: 0 [most prepared] to 22 [least prepared]); the 3-Item Care Transitions Measure (CTM-3) for quality of transition (range: 0 [worst transition] to 100 [best transition]); the 5-level EQ-5D version (EQ-5D-5L) for quality of life (range: 0 [dead] to 1 [full health]); and quality-adjusted life-years (QALY; range: 0 [dead] to 0.5 [full health at 6 months]). RESULTS: Among eligible patients, all 2494 (mean age, 77.7 years; 1258 [50.4%] women) completed the trial. There was no significant difference between the intervention and usual care groups in the first primary composite outcome (545 [49.4%] vs 698 [50.2%] events, respectively; hazard ratio [HR], 0.99 [95% CI, 0.83-1.19]) or in the second primary composite outcome (304 [27.5%] vs 408 [29.3%] events, respectively; HR, 0.93 [95% CI, 0.73-1.18]). There were significant differences between the intervention and usual care groups in the secondary outcomes of mean B-PREPARED score at 6 weeks (16.6 vs 13.9; difference, 2.65 [95% CI, 1.37-3.92]; P < .001); mean CTM-3 score at 6 weeks (76.5 vs 70.3; difference, 6.16 [95% CI, 0.90-11.43]; P = .02); and mean EQ-5D-5L score at 6 weeks (0.7 vs 0.7; difference, 0.06 [95% CI, 0.01 to 0.11]; P = .02) and 6 months (0.7 vs 0.6; difference, 0.06 [95% CI, 0.01-0.12]; P = .02). There was no significant difference in mean QALY between groups at 6 months (0.3 vs 0.3; difference, 0.00 [95% CI, -0.02 to 0.02]; P = .98). CONCLUSIONS AND RELEVANCE: Among patients with HF in Ontario, Canada, implementation of a patient-centered transitional care model compared with usual care did not improve a composite of clinical outcomes. Whether this type of intervention could be effective in other health care systems or locations would require further research. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02112227.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Van Spall HGC, Lee SF, Xie F, et al. Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure: The PACT-HF Randomized Clinical Trial. JAMA. 2019. PMID: 30806695. doi:10.1001/jama.2019.0710

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。